Business & Industry

roche-logo

South Africa negotiating with Roche to cut cancer drug prices

South Africa is in talks with pharmaceutical firm Roche to reduce the price of its breast cancer drug Herceptin, which cost 500,000 rand ($32,745) a year to treat one person and was unaffordable to most women, the health minister said on Tuesday. Africa’s most industrialized country has a history of pushing back against high medicine

novartis-logo

Novartis announces 300 million antimalarial treatments supplied without profit

Novartis has announced that the company has reached a delivery milestone of supplying 300 million pediatric antimalarial treatments without profit since 2009, helping to reduce the disease burden for children in more than 30 malaria-endemic countries. Coartem Dispersible is the first artemisinin-combination therapy (ACT) developed by Novartis in collaboration with Medicines for Malaria Venture (MMV)

IFC extends facility to Nigeria pharmacy chain, HealthPlus

The International Finance Corporation (IFC), a member of the World Bank Group, has announced an agreement with HealthPlus Limited and CasaBella International Limited to provide a $5 million loan facility that will help the two companies expand pharmaceutical and personal care services in Nigeria.

NovaBay-Pharma-Logo-101912

NovaBay signs distribution agreement with the Biopharm Group

NovaBay Pharmaceuticals, a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, has signed an exclusive distribution agreement for NovaBay’s NeutroPhase Skin and Wound Cleanser with the Biopharm Group, a leading pharmaceutical company in the Middle East, headquartered in Cairo, Egypt. Under the terms of the agreement, Biopharm will market NeutroPhase

Deals

OphamEdit-620x264

FMO, Adenia in leading pharmaceutical distributor in Madagascar

In the latest deal for its €96 million Fund III, Mauritius-headquartered private equity firm Adenia Partners is taking an undisclosed stake in Opham, a pharmaceutical products wholesaler in Madagascar. A family office and Dutch Development bank FMO invested alongside Adenia in the deal. The capital will be used to expand Opham’s operations, which currently distributes more

Policy & Regulatory Affairs

The Medicines Patent Pool Signs First Sub-licences for Hepatitis C Medicine Daclatasvir

Four companies to help speed access to curative direct-acting antiviral in 112 low- and middle-income countries The Medicines Patent Pool (MPP) has announced its first round of sub-licences for the generic production of Bristol-Myers Squibb’s daclatasvir, a direct-acting antiviral that is proven to help cure multiple genotypes of the hepatitis C virus. Generic companies Cipla,

The Medicines Patent Pool Signs First Sub-licences for Hepatitis C Medicine Daclatasvir

Four companies to help speed access to curative direct-acting antiviral in 112 low- and middle-income countries The Medicines Patent Pool (MPP) has announced its first round of sub-licences for the generic production of Bristol-Myers Squibb’s daclatasvir, a direct-acting antiviral that is proven to help cure multiple genotypes of the hepatitis C virus. Generic companies Cipla,

Pharma Projects

JohnsonJohnson_Logo

Johnson & Johnson unveils R300m plant makeover, targets growth in Nigeria

Johnson & Johnson have unveiled their modernised manufacturing plant in Cape Town, South Africa yesterday. The plant, located in Retret, underwent a R300 million upgrade to and is responsible for supplying more than 28 markets within Sub Sahara Africa. Pharmaceutical exports from South Africa amounted to R1.6 billion in 2013, of which more than half went

Plans set for new ARV production plant in Ghana

Oxford International Biomedical Ventures (OIBV), the ‘commercial arm’ of  United Kingdom-based charitable organisation Oxford International Biomedical Centre (OIBC) and the Government of Ghana (GoG) led by the Ministry of Environment, Science and Technology (MEST), are set to jointly establish a plant to manufacture anti-retroviral drugs and drugs for Priority Endemic Diseases in Ghana, OIBC said in a

People

Neimeth appoints acting MD/CEO

Neimeth International Pharmaceuticals Plc has announced the appointment of (Mrs.) Ebere Igboko Ekpunobi  as the acting Managing Director/CEO of the Company effective 23 November 2015 following the retirement of Mr. Emmanuel Princewill Ekunno. Dr. (Mrs.) Ebere Igboko Ekpunobi obtained a Bachelor of Pharmacy degree from the University of Nigeria Nsukka (1985) and a Master of

Press Releases

International

IFPMA_Logo_Full_Name

WHO, IFPMA launch cervical cancer campaign in Africa

There is need to support countries in setting up effective programmes against cancer, particularly cervical and breast cancers. Dr Andreas Ullrich, adviser to the assistant director general non-communicable diseases and mental cluster, World Health Organisation (WHO), said this in Kigali on Wednesday. He was briefing journalists about a new partnership that was launched on the

IFPMA_Logo_Full_Name

WHO, IFPMA launch cervical cancer campaign in Africa

There is need to support countries in setting up effective programmes against cancer, particularly cervical and breast cancers. Dr Andreas Ullrich, adviser to the assistant director general non-communicable diseases and mental cluster, World Health Organisation (WHO), said this in Kigali on Wednesday. He was briefing journalists about a new partnership that was launched on the

Top